Tags

Type your tag names separated by a space and hit enter

Current perspectives on statins.
J Indian Med Assoc. 2003 Jun; 101(6):381-3.JI

Abstract

As the epidemic of coronary artery disease rages on round the globe, research is always on to find suitable drugs to reverse the trend. While aspirin, beta-blockers and ACE inhibitors have been shown to reduce coronary mortality and morbidity, statins are rapidly coming to fore as another important cog in the wheel of primary and secondary prevention of coronary artery disease. Newer trial like Heart Protection Study suggests benefit of statin for high risk individuals, irrespective of initial serum cholesterol concentrations. This may be of great relevance in the Indian context taking into consideration the vast majority of coronary artery disease patients having normal to mildly elevated serum cholesterol in contrast to their western counterparts.

Authors+Show Affiliations

Mishra TK
Department of Cardiology, SCB Medical College, Cuttack 753 007.
Routray S
No affiliation info available

MeSH

AdultAgedAnticholesteremic AgentsCholesterolCholestyramine ResinCoronary Artery DiseaseFemaleHumansIndiaLovastatinMaleMiddle AgedPravastatinRandomized Controlled Trials as TopicSimvastatin

Pub Type(s)

Journal Article

Language

eng

PubMed ID

14579987

Citation

Mishra, Trinath Kumar, and Satyanarayan Routray. "Current Perspectives On Statins." Journal of the Indian Medical Association, vol. 101, no. 6, 2003, pp. 381-3.
Mishra TK, Routray S. Current perspectives on statins. J Indian Med Assoc. 2003;101(6):381-3.
Mishra, T. K., & Routray, S. (2003). Current perspectives on statins. Journal of the Indian Medical Association, 101(6), 381-3.
Mishra TK, Routray S. Current Perspectives On Statins. J Indian Med Assoc. 2003;101(6):381-3. PubMed PMID: 14579987.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Current perspectives on statins. AU - Mishra,Trinath Kumar, AU - Routray,Satyanarayan, PY - 2003/10/29/pubmed PY - 2003/12/3/medline PY - 2003/10/29/entrez SP - 381 EP - 3 JF - Journal of the Indian Medical Association JO - J Indian Med Assoc VL - 101 IS - 6 N2 - As the epidemic of coronary artery disease rages on round the globe, research is always on to find suitable drugs to reverse the trend. While aspirin, beta-blockers and ACE inhibitors have been shown to reduce coronary mortality and morbidity, statins are rapidly coming to fore as another important cog in the wheel of primary and secondary prevention of coronary artery disease. Newer trial like Heart Protection Study suggests benefit of statin for high risk individuals, irrespective of initial serum cholesterol concentrations. This may be of great relevance in the Indian context taking into consideration the vast majority of coronary artery disease patients having normal to mildly elevated serum cholesterol in contrast to their western counterparts. SN - 0019-5847 UR - https://www.unboundmedicine.com/medline/citation/14579987/Current_perspectives_on_statins_ DB - PRIME DP - Unbound Medicine ER -